Market Tracker

03/24 5:16pm ET

Imprimis Pharmaceuticals Inc (NASDAQ:IMMY)

2.82
Delayed Data
As of Mar 24
 +0.26 / +10.16%
Today’s Change
1.65
Today|||52-Week Range
4.47
+12.80%
Year-to-Date
No recent news for Imprimis Pharmaceuticals Inc.

Today’s Trading

Previous close2.56
Today’s open2.54
Day’s range2.54 - 2.88
Volume194,570
Average volume (3 months)105,582
Market cap$56.2M
Dividend yield--
Data as of 3:58pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)+9.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+105.25%
P/E ratioNM
Price/Sales1.60
Price/Book8.17

Competitors

 Today’s
change
Today’s
% change
MEIPMEI Pharma Inc-0.03-1.91%
OREXOrexigen Therapeutic...-0.02-0.50%
NBYNovaBay Pharmaceutic...0.000.00%
DRNADicerna Pharmaceutic...-0.04-1.50%
Data as of 3:59pm ET, 03/24/2017

Financials

Last reporting dateMarch 21, 2017
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$19.9M
Annual profit (last year)-$19.1M
Net profit margin-95.71%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Office &
Director
Mark L. Baum
Senior Vice President-
Operations
Clayton D. Edwards
Corporate headquarters
San Diego, California

Forecasts